With a daily gain of 3.38% and an Earnings Per Share (EPS) (EPS) of 3.16, Bath & Body Works Inc (BBWI, Financial) is a stock that has caught the attention of many investors. However, the question remains: is this stock a potential value trap that investors should think twice about? In this article, we will delve into a comprehensive valuation analysis of BBWI, providing you with the insights you need to make informed investment decisions.
An Overview of Bath & Body Works Inc (BBWI, Financial)
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2022. The company's stock price currently stands at $38.41, while the GF Value, an estimation of the fair value, is at $56.01. This discrepancy sets the stage for a deeper exploration of the company's value.
Understanding the GF Value
The GF Value is a proprietary measure of a stock's intrinsic value, computed based on historical trading multiples, a GuruFocus adjustment factor based on past performance and growth, and future business performance estimates. The GF Value Line gives an overview of the fair value that the stock should be traded at. If the stock price is significantly above the GF Value Line, it is overvalued, and its future return is likely to be poor. Conversely, if it is significantly below the GF Value Line, its future return will likely be higher.
For Bath & Body Works (BBWI, Financial), the stock gives every indication of being a possible value trap, according to GuruFocus Value calculation. At its current price of $38.41 per share and the market cap of $8.8 billion, Bath & Body Works stock gives every indication of being a possible value trap.
Link: These companies may deliver higher future returns at reduced risk.
Assessing Bath & Body Works' Financial Strength
Investing in companies with low financial strength could result in permanent capital loss, hence the need to carefully review a company's financial strength before deciding whether to buy shares. Bath & Body Works has a cash-to-debt ratio of 0.18, which ranks worse than 71.32% of companies in the Retail - Cyclical industry. Based on this, GuruFocus ranks Bath & Body Works's financial strength as 4 out of 10, suggesting a poor balance sheet.
Profitability and Growth
Investing in profitable companies carries less risk, especially in companies that have demonstrated consistent profitability over the long term. Bath & Body Works has been profitable 9 years over the past 10 years. Its operating margin of 17.01% is better than 90.48% of companies in the Retail - Cyclical industry, indicating strong profitability.
Growth is a crucial factor in the valuation of a company. The 3-year average annual revenue growth of Bath & Body Works is 18.6%, which ranks better than 79.98% of companies in the Retail - Cyclical industry. However, the 3-year average EBITDA growth rate is 7.1%, which ranks worse than 52.39% of companies in the same industry.
Comparing ROIC and WACC
One can evaluate a company's profitability by comparing its return on invested capital (ROIC) to its weighted average cost of capital (WACC). Bath & Body Works's ROIC is 27.45 while its WACC came in at 10.4, indicating that the company is likely creating value for its shareholders.
Is Bath & Body Works a Value Trap?
Despite some promising aspects, there are signs that Bath & Body Works might be a value trap. The company's 5-year revenue per share growth rate stands at -7.8%, indicating a decline in the company's revenue. This suggests that while the stock may appear undervalued, there are potential risks associated with this assessment.
Conclusion
Overall, Bath & Body Works (BBWI, Financial) stock gives every indication of being a possible value trap. The company's financial condition is poor, and its profitability is strong. Its growth ranks worse than 52.39% of companies in the Retail - Cyclical industry. To learn more about Bath & Body Works stock, you can check out its 30-Year Financials here.
To find out the high-quality companies that may deliver above-average returns, please check out GuruFocus High Quality Low Capex Screener.
